Assessing the mechanism of fast-cycling cancer-associated mutations of Rac1 small Rho GTPase.
Angela PariseAlessandra MagistratoPublished in: Protein science : a publication of the Protein Society (2024)
Rho-GTPases proteins function as molecular switches alternating from an active to an inactive state upon Guanosine triphosphate (GTP) binding and hydrolysis to Guanosine diphosphate (GDP). Among them, Rac subfamily regulates cell dynamics, being overexpressed in distinct cancer types. Notably, these proteins are object of frequent cancer-associated mutations at Pro29 (P29S, P29L, and P29Q). To assess the impact of these mutations on Rac1 structure and function, we performed extensive all-atom molecular dynamics simulations on wild-type (wt) and oncogenic isoforms of this protein in GDP- and GTP-bound states. Our results unprecedentedly elucidate that P29Q/S-induced structural and dynamical perturbations of Rac1 core domain weaken the binding of the catalytic site Mg 2+ ion, and reduce the GDP residence time within protein, enhancing the GDP/GTP exchange rate and Rac1 activity. This broadens our knowledge of the role of cancer-associated mutations on small GTPases mechanism supplying valuable information for future drug discovery efforts targeting specific Rac1 isoforms.
Keyphrases
- molecular dynamics simulations
- cell migration
- drug discovery
- binding protein
- wild type
- healthcare
- protein protein
- transcription factor
- stem cells
- cell therapy
- molecular docking
- papillary thyroid
- squamous cell carcinoma
- drug induced
- smooth muscle
- single molecule
- high intensity
- bone marrow
- drug delivery
- anti inflammatory
- diabetic rats
- crystal structure
- anaerobic digestion